The European Organization for Research and Treatment of Cancer approach to developing questionnaire modules: an update and overview. EORTC Quality of Life Study Group.
Authors:
- A CullACA Cull
- M GroenvoldMGM Groenvold
- K BjordalKBK Bjordal
- J BlazebyJBJ Blazeby
- N K AaronsonNAN K Aaronson
- 1 May 1998
- journal article
- Published by Kluwer Law International BV
- Vol. 7 (4) , 291-300
Abstract
The European Organization for Research and Treatment of Cancer (EORTC) Quality of Life Study Group has adopted a modular approach to quality of life (QoL) assessment in cancer clinical trials. The core instrument (the EORTC QLQ-C30) covers a range of QoL issues relevant to a broad spectrum of patients with cancer. The QLQ-C30 is designed to be supplemented by more specific subscales ('modules') to assess aspects of QoL of particular importance to specific subgroups of patients. Since individual members of the study group were to be involved in module development, guidelines were established. The primary aim of these guidelines was to standardize the module development process in order to ensure uniformly high quality across modules. This paper gives an update of the work completed to date. First, while the guidelines proved practical for module development, producing modules that exhibit adequate levels of psychometric and cross-cultural validity, experience pointed to three areas where the guidelines required more precision. These amendments will be provided and include (1) stricter monitoring of the developmental process from within the study group, (2) the explicit requirement of involvement of the study group and (3) a more precise definition of the criteria to be fulfilled before modules are allowed to be called 'EORTC modules'. Second, an overview of the modules currently under development or available for general use is provided. These modules include those for body image, high-dose chemotherapy, leukaemia, myeloma, palliative care and the following cancers: bladder, brain, breast, colorectal, head and neck, lung, oesophageal, ophthalmic, ovarian, pancreas and prostate. Finally, the need for the coordination of efforts in module development, both from within and outside the EORTC, is discussed.Keywords
This publication has 9 references indexed in Scilit:
- The European Organization for Research and Treatment of Cancer breast cancer-specific quality-of-life questionnaire module: first results from a three-country field study.Journal of Clinical Oncology, 1996
- Development of an EORTC questionnaire module to be used in quality of life assessment for patients with oesophageal cancerEuropean Journal of Cancer, 1996
- The development and psychometric validation of a brain cancer quality-of-life questionnaire for use in combination with general cancer-specific questionnairesQuality of Life Research, 1996
- A modular questionnaire for the assessment of longterm quality of life in leukaemia patients: The MRC/EORTC QLQ-LEUQuality of Life Research, 1996
- Development of a European Organization for Research and Treatment of Cancer (Eortc) Questionnaire Module to be Used in Quality of Life Assessments in Head and Neck Cancer PatientsActa Oncologica, 1994
- The EORTC QLQ-LC13: a modular supplement to the EORTC core quality of life questionnaire (QLQ-C30) for use in lung cancer clinical trialsEuropean Journal of Cancer, 1994
- The European Organization for Research and treatment of cancer approach to quality of life assessment: guidelines for developing questionnaire modulesQuality of Life Research, 1993
- The European Organization for Research and Treatment of Cancer QLQ-C30: A Quality-of-Life Instrument for Use in International Clinical Trials in OncologyJNCI: Journal of the National Cancer Institute, 1993
- A Modular Approach to Quality-of-Life Assessment in Cancer Clinical Trials1988